MDS Virtual Congress 2020 Archives - Page 39 of 149

Decreased Availability of Adenosine 2A Receptors in the Caudate in Patients with Early Stage Parkinson’s Disease

I. Waggan, E. Rissanen, J. Tuisku, J. Joutsa, S. Helin, R. Parkkola, J. Rinne, L. Airas (Turku, Finland)
Decreased Regional Cholinergic Signaling in Parkinson’s Disease

J. O'Donnell, Y. Zhou, M. Campbell, S. Mansor, B. Maiti, Z. Tu, J. Perlmutter (Saint Louis, MO, USA)
Deep Brain Stimulation (DBS) for Childhood Onset Dystonia

D. Munoz, M. Troncoso, D. Aguirre, E. Zambrano, R. Zepeda, S. Monsalve, R. Catalan, V. Naranjo, I. Ruiz, M. Hidalgo (Santiago, Chile)
Deep brain stimulation and cognitive decline in Parkinson’s disease: The predictive value of Alternate Fluency test

R. Ferrucci, F. Mameli, F. Ruggiero, M. Reitano, S. Marceglia, M. Massei, L. Borellini, F. Cogiamanian, T. Bocci, M. Locatelli, S. Barbieri, A. Averna, A. Priori (Milan, Italy)
Deep Brain Stimulation as the Only Advanced Therapy Available in the Dominican Rebublic, Report ot Two Cases in Centro Cardio Neuro Oftalmologico Y Transplante (Cecanot)

R. Cruz, A.A Perez (Santo Domingo, Dominican Republic)
Deep brain stimulation for generalized dystonia

K. Szalecki, T. Kmiec, H. Koziara, T. Mandat (Warszawa, Poland)
Deep Brain Stimulation for medically refractory tremor syndromes

A. Macerollo, D. Bhargava, B. Hammersley, J. Somerset, J. Osman-Farah (Liverpool, United Kingdom)
Deep Brain Stimulation impact on Social and Occupational Function in Parkinson’s Disease with Early Motor Complications

V. Stoker, P. Krack, L. Tonder, A. Schnitzler, J.L Houeto, J. Rau, C. Schade-Brittinger, M. Vidailhet, G. Deuschl (Minneapolis, MN, USA)
Deep brain stimulation in Parkinson’s disease: Selection criteria, post-surgery improvement and complications

F. Aziouaz, T. Dellal, Y. Mebrouk (Oujda, Morocco)
Deep brain stimulation in the treatment of camptocormia in Parkinson’s disease

Y. Lai, Y. Song, D. Su, L. Wang, C. Zhang, B. Sun, D. Li (Shanghai, China)